As we ring in 2017, on behalf of all the members of the scientific direction team of the Fonds de recherche du Québec – Santé (FRQS) and myself, I would like to wish you an excellent New Year that proves productive and brings new challenges.
After a fall marked by a range of consultations on the future of research and innovation in Québec and Canada, we will pursue our interventions as part of the development of the province's research and innovation strategy, which is expected to be unveiled by summer. We are also very closely following the announcements on the work of the panel mandated to review federal support for fundamental science and the consultation to develop a Canadian innovation policy. This optimal alignment of the research and innovation directions set out by Québec and Canada bodes well and underpins our efforts to increase the resources granted to the Fonds de recherche du Québec.
A new cycle of reflection and strategic consultation is about to get underway, and we will be resuming the university campus visits we began this past fall. These visits are the opportunity to share information and explore future avenues for development with members of the scientific community. In addition, the updated thematic networks program that was recently launched will bring new drive to scientific groups by further developing the international dimension. Finally, we will intensify our discussions with research centres and institutes as part of the health and social services reform initiative, which is moving rapidly.
The FRQS and biopharmaceutical company Merck Canada Inc. will soon be announcing the launch of the Oncopole, a new model to consolidate and develop concerted research efforts. The project will serve to increase the coherence of oncology research activities, speed up research commercialization and facilitate the translation of research results into clinical practices.
Finally, the FRQS will pursue its exchange efforts with other provinces through the National Alliance of Provincial Health Research Organizations (NAPHRO), as well as with its international partners.